Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | LST1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | RASD2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | CRHR1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | LIMCH1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | C9orf40 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | CTD-2192J16.22 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | TERF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | HOXA11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
mRNA | FDFT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
mRNA | TIMM10B | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |